These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 36432653)

  • 1. Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications.
    Ahmad A; Imran M; Sharma N
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Toxicity Implications of Multifunctional Drug Delivery Nanocarriers on Reproductive Systems
    Ahmad A
    Front Toxicol; 2022; 4():895667. PubMed ID: 35785262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Nanomedicine with Bio-Inspired Nanosystems: Recent Trends and Challenges in Mesenchymal Stem Cells Membrane-Coated Bioengineered Nanocarriers in Targeted Nanotherapeutics.
    Baig MS; Ahmad A; Pathan RR; Mishra RK
    J Xenobiot; 2024 Jun; 14(3):827-872. PubMed ID: 39051343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotoxicology and Nanosafety: Safety-By-Design and Testing at a Glance.
    Zielińska A; Costa B; Ferreira MV; Miguéis D; Louros JMS; Durazzo A; Lucarini M; Eder P; Chaud MV; Morsink M; Willemen N; Severino P; Santini A; Souto EB
    Int J Environ Res Public Health; 2020 Jun; 17(13):. PubMed ID: 32605255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primacy of physicochemical characterization of nanomaterials for reliable toxicity assessment: a review of the zebrafish nanotoxicology model.
    Bohnsack JP; Assemi S; Miller JD; Furgeson DY
    Methods Mol Biol; 2012; 926():261-316. PubMed ID: 22975971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
    Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
    ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro toxicity assessment of oral nanocarriers.
    Ciappellano SG; Tedesco E; Venturini M; Benetti F
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):381-401. PubMed ID: 27544694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At the Crossroads of Nanotoxicology in vitro: Past Achievements and Current Challenges.
    Hussain SM; Warheit DB; Ng SP; Comfort KK; Grabinski CM; Braydich-Stolle LK
    Toxicol Sci; 2015 Sep; 147(1):5-16. PubMed ID: 26310852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of nanotoxicology: implications for drug delivery and medical devices.
    Bhattacharjee S; Brayden DJ
    Nanomedicine (Lond); 2015 Jul; 10(14):2289-305. PubMed ID: 26114880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological Concerns of Engineered Nanosize Drug Delivery Systems.
    Mukherjee B; Maji R; Roychowdhury S; Ghosh S
    Am J Ther; 2016; 23(1):e139-50. PubMed ID: 24100254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology of Nanoparticles in Drug Delivery.
    Sharma S; Parveen R; Chatterji BP
    Curr Pathobiol Rep; 2021; 9(4):133-144. PubMed ID: 34840918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced nuclear analytical and related techniques for the growing challenges in nanotoxicology.
    Chen C; Li YF; Qu Y; Chai Z; Zhao Y
    Chem Soc Rev; 2013 Nov; 42(21):8266-303. PubMed ID: 23868609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives.
    Navya PN; Daima HK
    Nano Converg; 2016; 3(1):1. PubMed ID: 28191411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alginate Nanoformulation: Influence of Process and Selected Variables.
    Choukaife H; Doolaanea AA; Alfatama M
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of nanoparticles and routes of administration.
    Chenthamara D; Subramaniam S; Ramakrishnan SG; Krishnaswamy S; Essa MM; Lin FH; Qoronfleh MW
    Biomater Res; 2019; 23():20. PubMed ID: 31832232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs.
    Ojer P; Iglesias T; Azqueta A; Irache JM; López de Cerain A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):206-17. PubMed ID: 26493712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debunking some misconceptions about nanotoxicology.
    Warheit DB
    Nano Lett; 2010 Dec; 10(12):4777-82. PubMed ID: 21033694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.